“Knocking on the door of the ASX 100”: ACL makes $1.58b bid for healthcare giant Healius

 Australian Clinical Labs (ASX: ACL) has lobbed a $1.58 billion off-market offer to merge with one of its biggest competitors, Healius (ASX: HLS), as it looks to become the nation's largest pathology services provider and secure a deal that could have it "knocking on the door of the ASX 100". 

While ACL is the smaller of the two - with a market capitalisation of $726.6 million prior to its proposal - the Melbourne-based player believes it can help its larger rival turn around its operations, which posted a net profit loss of $28.7 million and earnings loss of $13.2 million in 1HFY23.

If the deal goes through, the combined entity will have 171 labs and 3,413 collection centres across the country, with expectations they will save up to $95 million over the next four years under the proposed combination of their labs, logistics, procurement benefits, back-office activities and overlapping IT systems.

Read More: https://www.businessnewsaustralia.com/articles/australian-clinical-labs-makes-1-5b-bid-for-healthcare-giant-healius.html



Comments

Popular posts from this blog

Final say on Crown Perth oversight stays with government despite scathing royal commission

Fortress Australia needs to open its doors to international students

Come inside the RBA's media lock-ups to see how we report on interest rates and financial risks